Amiodarone-induced alveolar hemorrhage

Southern Medical Journal

Volumn 99, Issue 4, 2006, Pages 383-387

  Iskandar, Said B ^b   Abi Saleh, Bernard ^b   Keith, Rob L ^b   Byrd Jr , Ryland P ^a   Roy, Thomas M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Alveolar hemorrhage; Amiodarone; Pulmonary toxicity

Indexed keywords

AMIODARONE;

AGED; ARTICLE; CASE REPORT; CORNEA DISEASE; DRUG FATALITY; DRUG INDUCED DISEASE; HEART ARRHYTHMIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; LIVER DISEASE; LUNG HEMORRHAGE; MALE; NEUROMUSCULAR DISEASE; PNEUMONIA; SKIN DISEASE; THYROID DISEASE;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HEMORRHAGE; HUMANS; LUNG DISEASES; MALE; PULMONARY ALVEOLI; TACHYCARDIA, VENTRICULAR;

EID: 33646485240     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000208971.43461.bb     Document Type: Article

References (24)

1. Connolly SJ. Evidence based analysis of amiodarone efficacy and safety. Circulation 1999;100:2025-2034.
2. Brinker A, Johnston M. Acute pulmonary injury in association with amiodarone, Chest 2004;125:1591-1592.
3. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997;350:1417-1424.
4. Magro SA, Lawrence EC, Wheeler SH, et al. Amiodarone pulmonary toxicity: prospective evaluation of serial pulmonary function tests. J Am Coll Cardiol 1988;12:781-788.
5. Kudenchuk PJ, Pierson DJ, Greene HL, et al. Prospective evaluation of amiodarone pulmonary toxicity. Chest 1984;86:541-548.
6. Dean PJ, Groshart KD, Porterfield JG, et al. Amiodarone-associated pulmonary toxicity: a clinical and pathologic study of eleven cases. Am J Clin Pathol 1987;87:7-13.
7. Iskander S, Raible DG, Brozena SC, et al. Acute alveolar hemorrhage and orthodeoxia induced by intravenous amiodarone. Catheter Cardiovasc Interv 1999;47:61-63.
8. Goldstein I, Topilsky M, Segev D, et al. Very early onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. Chest 1997; 111:1446-1447.
9. Vizioli LD, Cho S. Amiodarone-associated hemoptysis. Chest 1994;105:305-306.
10. Camus P, Martin II, WJ Rosenow EC III. Amiodarone pulmonary toxicity. Clin Chest Med 2004;25:65-75.
11. Zitnik RJ. Drug-induced lung disease: anti-arrhythmic agents. J Respir Dis 1996;17:254-270.
12. Valle JM, Alvarez D, Antunez J, et al. Bronchiolitis obliterans organizing pneumonia secondary to amiodarone: a rare aetiology. Eur Respir J 1995;8:470-471.
13. Arnon R, Raz I, Chajek-Shaul T, et al. Amiodarone pulmonary toxicity presenting as a solitary lung mass. Chest 1998;93:425-427.
14. Naccarelli GV, Wolbrette DL, Patel HM, et al. Amiodarone: clinical trials. Curr Opin Cardiol 2000;15:64-72.
15. Morady F, Sauve MJ, Malone P, et al. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Am J Cardiol 1983;52:975-979.
16. Martin WJ II, Rosenow EC III. Amiodarone pulmonary toxicity: recognition and pathogenesis. Chest 1988;93:1067-1075.
17. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245.
18. Costabel U, Uzaslan E, Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med 2004;25:25-35.
19. Grebski E, Hess T, Hold G, et al. Diagnostic value of hemosiderin-containing macrophages in bronchoalveolar lavage. Chest 1992;102:1794-1799.
20. Sanoski CA, Bauman JL. Clinical observations with the amiodarone/ warfarin interaction: dosing relationships with long-term therapy. Chest 2002;121:19-23.
21. Fraire AE, Guntupalli KK, Greenberg SD, et al. Amiodarone pulmonary toxicity: a multi-disciplinary review of current status. South Med J 1993;86:67-77.
22. Gutierrez R, Del Pozo, J Carrion C, et al. Vasculitis associated with amiodarone treatment. Ann Pharmacother 1994;28:537.
23. Zaher C, Hamer A, Peter T, et al. Low dose steroid therapy for prophylaxis of amiodarone-induced pulmonary infiltrates. N Engl J Med 1983;308:779.
24. Singh BN. Amiodarone: the expanding anti-arrhythmic role and how to follow a patient on chronic therapy. Clin Cardiol 1997;20:608-618.